Cargando…

Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review()()

Lacosamide (LCM) is a novel antiepileptic drug (AED) approved by the FDA for adjunctive treatment of partial epilepsy with and without secondary generalization. Lacosamide dose-dependent dysrhythmias (PR-interval prolongation, AV block, and atrial fibrillation/flutter) have been reported. This case...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaufman, Kenneth R., Velez, Arnaldo E., Wong, Stephen, Mani, Ram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150593/ https://www.ncbi.nlm.nih.gov/pubmed/25688049 http://dx.doi.org/10.1016/j.ebcr.2012.10.006

Ejemplares similares

Lacosamide-Related Arrhythmias: A Systematic Analysis and Review of the Literature
por: Yadav, Ruchi, et al.
Publicado: (2021)

Lacosamide dosing in patients receiving continuous renal replacement therapy
por: Chaijamorn, Weerachai, et al.
Publicado: (2023)

Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior()()
por: Kaufman, Kenneth R., et al.
Publicado: (2013)

Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy
por: Ziegler, Dan, et al.
Publicado: (2010)

Lacosamide in Pediatric Status Epilepticus
por: Piantino, Juan A.
Publicado: (2017)

Lacosamide: Inefficacy: case report
Publicado: (2021)

Lacosamide poisoning improved by hemodialysis
por: Takahashi, Hiroki, et al.
Publicado: (2022)

Benefits of prescribing low-dose digoxin in atrial fibrillation
por: Rosca, Ciprian Ilie, et al.
Publicado: (2021)

Lacosamide at therapeutic concentrations induces histone hyperacetylation in vitro
por: Granit, Avital, et al.
Publicado: (2018)

Unmasking of myoclonus by lacosamide in generalized epilepsy
por: Birnbaum, Daniel, et al.
Publicado: (2016)

Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain
por: Bainbridge, Jacquelyn, et al.
Publicado: (2017)

Drug-induced dermatomyositis after lacosamide: A case report
por: Gaffney, Rebecca G., et al.
Publicado: (2018)

Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis
por: Shibata, Makoto, et al.
Publicado: (2021)

Lacosamide monotherapy in clinical practice: A retrospective chart review
por: Villanueva, V., et al.
Publicado: (2018)

Lacosamide in the general population and in people with intellectual disability: Similar responses?
por: Allard, Jon, et al.
Publicado: (2020)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

Atrial fibrillation and hyperthyroidism: A literature review
por: Reddy, Vivek, et al.
Publicado: (2017)

Safety of lacosamide in children with refractory partial epilepsy
por: Pasha, Ismail, et al.
Publicado: (2015)

Efficacy of (S)-lacosamide in preclinical models of cephalic pain
por: Moutal, Aubin, et al.
Publicado: (2016)

Development of lacosamide for the treatment of partial-onset seizures
por: Doty, Pamela, et al.
Publicado: (2013)

A case of auditory disturbance caused by lacosamide
por: Kawai, Mihoko, et al.
Publicado: (2019)

Lacosamide Associated Complete Heart Block in Elderly
por: Bhana, Indu Ghanshyam, et al.
Publicado: (2019)

The effect of lacosamide on psychiatric comorbidities in patients with epilepsy
por: Hasegawa, Naoya, et al.
Publicado: (2020)

Refractory Ventricular Tachycardia and Seizures With Lacosamide Overdose
por: Marcellino, Chris, et al.
Publicado: (2022)

The therapeutic effects of lacosamide on epilepsy-associated comorbidities
por: He, Zihua, et al.
Publicado: (2023)

Lacosamide-induced excessive laughing in a patient with Lennox–Gastaut syndrome
por: Algahtani, Hussein, et al.
Publicado: (2018)

Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation
por: Perreault, Sylvie, et al.
Publicado: (2022)

Atrial fibrillation ablation–induced gastroparesis: A case report and literature review
por: Akhtar, Tauseef, et al.
Publicado: (2020)

Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation
por: Perreault, Sylvie, et al.
Publicado: (2022)

Lacosamide for the prevention of partial onset seizures in epileptic adults
por: Kelemen, Anna, et al.
Publicado: (2010)

DRESS syndrome: A case of cross‐reactivity with lacosamide?
por: Fong, Man Kei, et al.
Publicado: (2017)

Genomic and clinical predictors of lacosamide response in refractory epilepsies
por: Heavin, Sinéad B., et al.
Publicado: (2019)

Effects of lacosamide and carbamazepine on lipids in a randomized trial
por: Mintzer, Scott, et al.
Publicado: (2020)

Lacosamide/levetiracetam/valproate: Lack of efficacy: case report
Publicado: (2022)

Lacosamide decreases neonatal seizures without increasing apoptosis
por: Langton, Rachel L., et al.
Publicado: (2022)

Effectiveness and tolerability of lacosamide in children with drug resistant epilepsy
por: Driessen, J.T., et al.
Publicado: (2022)

Therapeutic drug monitoring of lacosamide among children: is it helpful?
por: Kohn, Elkana, et al.
Publicado: (2023)

Three cases in which drug‐induced hyponatremia was improved by replacing carbamazepine with lacosamide
por: Morimoto, Masahito, et al.
Publicado: (2020)

Lacosamide induced Brugada I morphology in the setting of septicemia: A case report
por: Goodnough, Robert, et al.
Publicado: (2021)

Epileptic seizure-induced syncopal asystole reversed by lacosamide: a case report
por: Fitouchi, S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c97e5f9m1tb43vus5461rcqo04